Jpmorgan Chase & CO Immunocore Holdings PLC Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,538 shares of IMCR stock, worth $148,982. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,538
Previous 11,275
59.75%
Holding current value
$148,982
Previous $382,000
63.09%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IMCR
# of Institutions
141Shares Held
41.4MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$231 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$213 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$160 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$81.2 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$70.8 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.44B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...